ReviewCurrent opinion in HIV and AIDS2017
Cancer care disparities in people with HIV in the United States.
Review in Current opinion in HIV and AIDS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 32 citations in OpenAlex.
- Cancer Screening Behaviors among People with HIV in the United States and the Role of Multi-Level Social and Economic Factors: A Systematic Review.Current epidemiology reports · 2026Article
- Geospatial Access to CAR-T Clinical Trials for Non-Hodgkin Lymphoma for Persons With HIV.JAMA network open · 2026Article
- Article
- Social and Healthcare Disruptions Due to the COVID-19 Pandemic and Associations with Psychosocial Well-Being Among Cancer Survivors With and Without HIV: Findings from the MACS/WIHS Combined Cohort Study.AIDS and behavior · 2026Article
- Inequities by race and ethnicity in cancer treatment receipt among people living with HIV and cancer in the U.S. (2004-2020).BMC cancer · 2025Article
- Inequities in palliative care delivery to patients with HIV and stage IV cancers in the United States (2004-2020).JNCI cancer spectrum · 2025Article
- Cancer in People with HIV.Infectious disease clinics of North America · 2024Review
- A clinical overview of people living with HIV and genitourinary cancer care.Nature reviews. Urology · 2024Review
- Survival by sex and HIV status in patients with anal cancer in the USA between 2001 and 2019: a retrospective cohort study.The lancet. HIV · 2024Article
- Pembrolizumab in an HIV-infected patient with glioblastoma.Immunotherapy · 2024Article
- Lung cancer screening adherence among people living with and without HIV: An analysis of an integrated health system in Florida, United States (2012-2021).Preventive medicine reports · 2023Article
- Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma.JHEP reports : innovation in hepatology · 2023Article
- Diffuse Large B-Cell Lymphoma in the HIV Setting.Cancers · 2023Review
- Palliative Care Use Among People Living With HIV and Cancer: An Analysis of the National Cancer Database (2004-2018).JCO oncology practice · 2022Article
- Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer.Journal for immunotherapy of cancer · 2022Article
- The Impact of HIV on Non-AIDS defining gastrointestinal malignancies: A review.Seminars in oncology · 2021Review
- Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Article
- Article
- Outcomes Following Major Oncologic Operations for Non-AIDS-Defining Cancers in the HIV Population: A Matched Comparison to the General Population.World journal of surgery · 2019Article
- Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus.AIDS research and human retroviruses · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
purpose of reviewCancer is a growing problem in the HIV population, in large part because of aging of HIV-infected people treated with antiretroviral therapy. Overall and cancer-specific survival is worse in HIV-infected cancer patients compared with uninfected patients. One potential reason for the observed survival deficit is differences in cancer treatment. RECENT
findingsRecent population-based data suggest that HIV-infected cancer patients are less likely to receive cancer treatment compared with uninfected patients. This review describes these treatment disparities and their impact on patient outcomes, explores reasons for the disparity and highlights areas for future research. SUMMARY: Cancer is the leading cause of non-AIDS death in HIV-infected individuals. Understanding the underlying cancer treatment disparity between HIV-infected patients and their uninfected counterparts, and developing solutions to address the problem, is of great importance to improve cancer outcomes in this growing patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.